MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

September 2003



Putting ALLHAT into Perspective

The media had a field day with the ALLHAT study, but its findings need to be placed into the context of a larger body of evidence.
David B. Nash, MD, MBA, and Janice L. Clarke, RN, BBA

Health Care and Law

Maine’s Plan to Lower Drug Costs for the Uninsured Passes a Major Legal Test

A plan from Maine to reduce health care costs for uninsured patients could become a model for the nation.
Robert I. Field, JD, MPH, PhD

Principles of Antibiotic Formulary Selection for P&T Committees, Part 4: Antimicrobial Side Effects

Dr. Cunha describes some adverse consequences of antimicrobial therapy.
Burke A. Cunha, MD

Continuing Education Credit

Antiretroviral Therapy in HIV-Infected Adults, Part 2: Review of Selected Agents

The authors provide an overview of the major antiretroviral medications used to treat AIDS and HIV infection.
Eli Korner, PharmD, MPH, Mary Ellen Bonk, PharmD, Thomas Ratko, PhD, and Karl A. Matuszewski, MS, PharmD



The Emperor’s New Clothes? A $12 Million Tale

Dr. Matuszewski has several theories as to why we’re listening to the Leapfrog Group’s advice on CPOE.
Karl A. Matuszewski, MS, PharmD

Prescription Washington

DEA Seeks to Reduce Pharmacy Costs on Ordering Controlled Substances

Stephen Barlas discusses the DEA’s proposal to cut costs on ordering controlled substances.
Stephen Barlas

Medication Errors

Dangers of Peritoneal Dialysis Solutions When Knowledge of Physiology Is Poor

Matthew Grissinger demonstrates why pharmacists need to understand physiology in order to prepare peritoneal dialysis solutions.
Matthew Grissinger, RPh, FASCP

Drug News

New Drugs/Drug News

P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA.

Drug Forecast

Enfuvirtide: A Novel Agent for Inhibiting the Entry of HIV-1 into Immune Cells

The authors review enfuvirtide (Fuzeon®), a new agent for the treatment of HIV-1 infection.
Nathaniel Eraikhuemen, PharmD, Evans Branch III, PharmD, Naomi Boston, PharmD, Marlon Honeywell, PharmD, and Kevin Sneed, PharmD

P&T Snapshot

The Use of Diuretics in Hypertension

ALLHAT and Diuretics